首页>
外国专利>
Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
展开▼
机译:抑制补体C5激活以治疗和预防延迟异种移植或急性血管排斥
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to C5 inhibitors, which inhibit type II endothelial cell activation, wherein the inhibition is manifested by the suppression of E-selectin. These inhibitors are useful in treatment of delayed xenograft rejection or acute vascular rejection. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab')2 and Fv, small molecules, including peptides, oligonucleotides, peptidominetics and organic compounds. Examples of monoclonal antibodies, which bind to and inhibit C5, were generated and are designated MAb 137-76 and MAb 137-30.
展开▼